Evidence map›Paper›PMID 34596053›Full record

ReviewThe Journal of clinical investigation2021

Circadian disruption and human health.

Anna B Fishbein, Kristen L Knutson, Phyllis C Zee

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 232 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
232citing papers in PubMed, 9 pooled it
20.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

232 citing papers in PubMed, 9 syntheses or guidelines pooled it, 381 citations in OpenAlex.

  1. Circadian clock regulation of hemostasis: a systematic review of molecular pathways.Research and practice in thrombosis and haemostasis · 2026
    Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

172 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anna B FishbeinDepartment of Pediatrics, Division of Pediatric Allergy and Immunology, Ann & Robert H. Lurie Children's Hospital, and.
Kristen L KnutsonDepartment of Neurology and Center for Circadian and Sleep Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Phyllis C ZeeDepartment of Neurology and Center for Circadian and Sleep Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Circadian (United States) · USLurie Children's Hospital · USNorthwestern University · US

Funding

SLOW WAVE SLEEP AND TYPE 2 DIABETES RISK IN AGINGP01AG011412 · NIA · UNIVERSITY OF CHICAGO · PI ZEE, PHYLLIS C. · 1994 to 2021
$31.5M
TRAINING GRANT IN SLEEP RESEARCHT32HL007909 · NHLBI · NORTHWESTERN UNIVERSITY · PI FRED W TUREK, Phyllis C. Zee · 1998 to 2026
$9.2M
Pathogenic mechanisms of Neuro-PASC in older adultsR01AG059291 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CARNETHON, MERCEDES RENEE, KNUTSON, KRISTEN · 2019 to 2023
$4.7M
Strengthening circadian signals to enhance cardiometabolic functionR01HL140580 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ZEE, PHYLLIS C. · 2017 to 2021
$3.4M
Leveraging a Unique existing Cohort to elucidate the Link between sleep and cardio-metabolic diseaseR01HL141881 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KNUTSON, KRISTEN · 2019 to 2022
$2.7M
Circadian Rhythms of Skin Barrier, Pruritus and Inflammation in Atopic DermatitisK23AR075108 · NIAMS · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI FISHBEIN, ANNA B · 2019 to 2022
$674k
NHLBI NIH HHS R01 HL140580NHLBI NIH HHS R01 HL141881NHLBI NIH HHS T32 HL007909NIAMS NIH HHS K23 AR075108NIA NIH HHS P01 AG011412NIA NIH HHS R01 AG059291
6 · The paper itself

Abstract

Circadian disruption is pervasive and can occur at multiple organizational levels, contributing to poor health outcomes at individual and population levels. Evidence points to a bidirectional relationship, in that circadian disruption increases disease severity and many diseases can disrupt circadian rhythms. Importantly, circadian disruption can increase the risk for the expression and development of neurologic, psychiatric, cardiometabolic, and immune disorders. Thus, harnessing the rich findings from preclinical and translational research in circadian biology to enhance health via circadian-based approaches represents a unique opportunity for personalized/precision medicine and overall societal well-being. In this Review, we discuss the implications of circadian disruption for human health using a bench-to-bedside approach. Evidence from preclinical and translational science is applied to a clinical and population-based approach. Given the broad implications of circadian regulation for human health, this Review focuses its discussion on selected examples in neurologic, psychiatric, metabolic, cardiovascular, allergic, and immunologic disorders that highlight the interrelatedness between circadian disruption and human disease and the potential of circadian-based interventions, such as bright light therapy and exogenous melatonin, as well as chronotherapy to improve and/or modify disease outcomes.

Indexed as

BiomarkersCardiovascular DiseasesCircadian RhythmHumansMental DisordersMetabolic DiseasesNeurodegenerative DiseasesNeurodevelopmental DisordersPublic HealthBiomarkers

Identifiers

PMID34596053
PMCPMC8483747
OpenAlexW3203847771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.